Transcription of BRACKETING AND MATRIXING DESIGNS FOR STABILITY …
{{id}} {{{paragraph}}}
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE BRACKETING AND MATRIXING DESIGNS FOR STABILITY testing OF NEW DRUG SUBSTANCES AND PRODUCTS Q1D Current Step 4 version dated 7 February 2002 This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. Q1D Document History First Codification History Date New Codification November 2005 Q1D Approval by the Steering Committee under Step 2 and release for public consultation.
BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS 1. INTRODUCTION 1.1 Objectives of the Guideline This guideline is intended to address recommendations on the application of bracketing and matrixing to stability studies conducted in accordance with
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}